Adma Biologics
(NASDAQ) ADMA
Adma Biologics Financials at a Glance
Market Cap
$2.19B
Revenue (TTM)
$510.17M
Net Income (TTM)
$146.93M
EPS (TTM)
$0.60
P/E Ratio
15.34
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$9.19
Volume
6,126,506.594
Open
$8.90
Price
$9.19
Volume
6,126,506.594
Open
$8.90
Previous Close
$9.19
Daily Range
$8.80 - $9.26
52-Week Range
$7.21 - $25.67
Dividend
$0.00
Beta (Volatility)
1.20 (Average)
Price
$9.19
Volume
6,126,506.594
Open
$8.90
Previous Close
$9.19
Daily Range
$8.80 - $9.26
52-Week Range
$7.21 - $25.67
ADMA News
ADMA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adma Biologics
Industry
Biotechnology
Sector
Health CareEmployees
647
CEO
Adam S. Grossman
Website
www.admabiologics.comHeadquarters
Ramsey, NJ 07446, US
ADMA Financials
Key Financial Metrics (TTM)
Gross Margin
57%
Operating Margin
38%
Net Income Margin
29%
Return on Equity
36%
Return on Capital
35%
Return on Assets
24%
Earnings Yield
6.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.19B
Shares Outstanding
238.16M
Volume
6.13M
Short Interest
0.00%
Avg. Volume
4.94M
Financials (TTM)
Gross Profit
$292.76M
Operating Income
$191.44M
EBITDA
$197.86M
Operating Cash Flow
$50.40M
Capital Expenditure
$22.57M
Free Cash Flow
$27.82M
Cash & ST Invst.
$87.63M
Total Debt
$79.89M
Adma Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$139.16M
+18.4%
Gross Profit
$88.82M
+40.2%
Gross Margin
63.82%
N/A
Market Cap
$2.19B
N/A
Market Cap/Employee
$3.20M
N/A
Employees
685
N/A
Net Income
$49.38M
-55.9%
EBITDA
$65.27M
+65.1%
Quarterly Fundamentals
Net Cash
$7.75M
-63.2%
Accounts Receivable
$158.43M
+216.9%
Inventory
$206.47M
+21.3%
Long Term Debt
$75.98M
-6.1%
Short Term Debt
$3.91M
+220.9%
Return on Assets
23.54%
N/A
Return on Invested Capital
34.51%
N/A
Free Cash Flow
$34.55M
-27.2%
Operating Cash Flow
$35.64M
-29.0%